Licensee's Work Sample Clauses

Licensee's Work. The Licensee, at its sole cost and expense, shall obtain all necessary permits and other authorizations required by the County and other applicable government entities before commencing any work in the County’s Rights-of-Way or the Public Rights-of-Way. The Licensee, its contractors, and their respective employees shall comply with all applicable safety requirements and construction Codes and standards. Nothing in this Agreement shall be deemed to waive or suspend any such requirement. The Licensee shall notify the County in writing (email is acceptable) 72 hours prior to commencing work, in any such Rights-of-Way, on any of the Licensee's Equipment connected to the County Network. The Licensee's work shall not interfere with, disrupt, or adversely affect the County Network or any authorized third party's use thereof, or the operations, facilities, or services of any affected Facility Third Party. The Licensee shall ensure that work performed by or on behalf of the Licensee and its agents on the Licensee's Equipment satisfies the work qualification requirements set forth in the Administrative Rules, and conforms in all other respects to the Administrative Rules. The Licensee shall ensure that all work done on the Licensee’s behalf in connection with the installation of facilities to be connected to the County Network at an Interconnection Point shall be performed by contractors selected from a list of contractors previously approved by the County. The Licensee shall be solely responsible to the selected contractor for the cost of installation. No work will be done without the presence of a County inspector.
Sample 1Sample 2Sample 3See All (4)
AutoNDA by SimpleDocs
Licensee's Work a) The Licensee shall, at its own expense, install, attach, repair, operate and maintain its Equipment in accordance with Scheduled “A” and in a good and workmanlike manner. All installation, reconfiguration, attachment, maintenance, repair and operation to be carried out under this License by the Licensee shall be done at the Licensee's expense and risk. Upon the expiration or earlier termination of this License, the Licensee agrees to repair at the Licensee's sole cost and expense to the reasonable satisfaction of the Licensor, all damages, structural or otherwise, save and except for reasonable wear and tear, that may be caused to the Licensor's property, including all buildings on the Property, by reason of the installation, reconfiguration, attachment, maintenance, operation or removal of the Licensee's Equipment.
Sample 1
Licensee's Work. Any Licensee improvements and other work shall be performed by Licensee, at Licensee’s own cost. Licensee shall perform, at Licensee’s sole cost and expense, any work to the Licensed Area necessary to make the Licensed Area suitable for Licensee’s operations (“Licensee’s Work”). All such work shall be subject to Licensor’s advance written approval. Licensee shall not make any alterations or improvements to the Licensed Area without Licensor’s advance written consent, to be given or withheld in Licensor’s sole and absolute discretion. Licensee shall secure all necessary permits, authorization and approvals which may be required, and shall at all times comply with all government rules and regulations, ordinance, statutes, and laws now or hereinafter in force pertaining to the Licensed Area and the Property and Licensee’s use thereof, and shall provide Licensor with copies of same. Licensee shall not conduct, or permit to be conducted, any construction activity at the Licensed Area or Property without Licensor’s prior written approval. Licensee shall pay all taxes based on any property of Licensee, real or personal, which shall at any time be in the Licensed Area or any other part of the Property, including Licensee’s installations, additions, improvements, fixtures, and personal property. Licensee shall not suffer any mechanic’s lien to be filed against the Licensed Area or any other part of the Property by reason of any work, labor, services, or materials performed at or furnished to the Licensed Area for Licensee or anyone holding the Licensed Area through or under Licensee. If a mechanic’s lien shall be filed, Licensor shall remove it at Licensee’s sole cost and expense, and Licensee shall indemnify, defend, and hold harmless the Indemnified Parties (defined below) from any all claims, causes of action, damages or other losses arising out of a mechanics lien placed upon the Licensed Area or the Property as a result of work commissioned by, or materials furnished to, Licensee.
Sample 1
Licensee's Work. Licensee and its agents shall at all times perform its work in accordance with the applicable provisions of OSHA, the National Electrical Safety Code and Niagara Mohawk policies and standards for work upon and around, repair and maintenance of Electric Transmission Poles and Cables attached and thereto. Niagara Mohawk shall have the authority to suspend Licensee's work operations in and around Niagara Mohawk's Property if at any time hazardous conditions arise or any unsafe practices are being followed by Licensee's employees, agents, and contractors. Licensee agrees to pay Niagara Mohawk for having Niagara Mohawk's employee or agent present when Licensee's work is being done in and around Niagara Mohawk's property. Such charges shall be at Niagara Mohawk's Actual Cost. The presence of Niagara Mohawk's authorized employee or agent(s) shall not relieve Licensee of its responsibility to conduct all of its work operations in and around Niagara Mohawk's Property in a safe and workmanlike manner, and in accordance with the terms and conditions of this Agreement.
Sample 1

Related to Licensee's Work

  • Licensed Territory Worldwide NIH Patent License Agreement—Exclusive APPENDIX C – ROYALTIES Royalties:

  • Licensed Products Lessee will obtain no title to Licensed Products which will at all times remain the property of the owner of the Licensed Products. A license from the owner may be required and it is Lessee's responsibility to obtain any required license before the use of the Licensed Products. Lessee agrees to treat the Licensed Products as confidential information of the owner, to observe all copyright restrictions, and not to reproduce or sell the Licensed Products.

  • Commercialization Diligence Novartis shall dedicate commercially reasonable efforts, during each [**] month period, necessary to commercialize a Licensed Product for a Profile, after receipt of Regulatory Approval therefor, in any of the U.S., Japan or the EU Major Market Countries. If Novartis commercializes a Licensed Product for a Profile, after receipt of Regulatory Approval therefor, in any of the U.S., Japan or the EU Major Market Countries, Novartis will be deemed to satisfy all diligence obligations with respect to such Profile.

  • LICENSE TERM The license term shall commence upon the License Effective Date, provided, however, that where an acceptance or trial period applies to the Product, the License Term shall be extended by the time period for testing, acceptance or trial.

  • Research Program 2.1 University will use reasonable efforts to conduct the Research Program described in Attachment A which is hereby incorporated in full by reference (“Research Program”), and will furnish the facilities necessary to carry out said Research Program. The Research Program will be under the direction of _____________________ (“Principal Investigator”), or his or her successor as mutually agreed to by the Parties and will be con­ducted by the Principal Investigator at the University.

  • Research Plans The Research Plan for the [***] Designated Target is attached as Schedule 2.2.3-1. Subsequent Research Plans agreed upon in accordance with Section 2.4.2.4 will be attached as additional sequentially numbered schedules (Schedule 2.2.3-2, Schedule 2.2.3-3, etc.).

  • Research Program Term The Research Program shall be conducted during the period of five years commencing as of the Agreement Date ("Research Program Term"). Upon not later than seventy-five (75) days' prior written notice JT may, in its sole judgment, terminate the Research Program at the end of the third (3/rd/) year and fourth (4/th/) year of the Research Program. The RMC may terminate the Research Program any time during the Research Program Term if it unanimously determines the Research Program is no longer scientifically useful or that all potential Products would not be commercially viable. In case of such an early termination by JT or the RMC, JT shall be exempt from any payment(s) under Section 10(a) that would have become due and payable after the effective date of such early termination. Following any termination of the Research Program (i) that occurs simultaneously with the termination of this Agreement in accordance with Section 13 (i.e., no compound or Lead Compound has been designated previously a Collaboration Lead Compound in accordance with Section 3(b) and no Independent Lead Compound is being developed in accordance with Section 3(m)) or (ii) that is followed at some future date by the termination by JT of Development or co-promotion of any Collaboration Lead Compound and/or Product pursuant to Sections 3(l) or 5(c), respectively, or development of an Independent Lead Compound in accordance with Section 3(m) (A) any licenses granted by Tularik to JT will terminate, (B) JT will grant to Tularik an exclusive, sublicensable, worldwide license, to make, use and sell compounds, Collaboration Lead Compounds or Products under JT's interest in Program Patents and Program Know-How and (C) under the terms and conditions to be separately agreed, JT will also grant to Tularik a nonexclusive, sublicensable, worldwide license under any JT Patent Rights and Know-How to the extent necessary to practice the license granted under the Program Patents and Program Know-How in (B) (including, with respect to compounds, a limited number of JT's library compounds approved by JT); provided, however, that in the event the Research Program terminates but the Agreement has not terminated with respect to designated Collaboration Lead Compounds, Independent Lead Compounds and/or Products as provided in Section 2(g)(ii), Sections 2(g)(A), (B) and (C) shall apply only to those compounds, Collaboration Lead Compounds, Independent Lead Compounds and Products for which Development or co-promotion shall have been terminated and/or to those compounds or Lead Compounds that have not been designated previously a Collaboration Lead Compound in accordance with Section 3(b) or an Independent Lead Compound in accordance with Section 3(m); provided further that in the event that JT elects to pursue a Discontinued Compound or a Non-Proposed Compound on or before the first anniversary of the expiration or termination of the Research Program Term pursuant to Section 3(b)(iii) or 3(b)(iv), respectively, Sections 2(g)(A), (B) and (C) shall not apply to such Discontinued Compound or Non-Proposed Compound until such time as JT shall have terminated the Development or co-promotion of such Discontinued Compound or Non- Proposed Compound. Tularik will then be free to pursue clinical development and registration of such compounds, Lead Compounds and/or Products without obligation to JT except as provided in Section 4(f) or Section 5(c), as appropriate.

  • Licensee Licensee represents and warrants that:

  • Development and Regulatory Milestones With respect to each of the following milestones, Ikaria shall pay BioLineRx the corresponding payment set forth below within [**] days after the achievement by Ikaria, its Affiliates or Licensees of such milestone: MILESTONE PAYMENT

  • Research Plan The Parties recognize that the Research Plan describes the collaborative research and development activities they will undertake and that interim research goals set forth in the Research Plan are good faith guidelines. Should events occur that require modification of these goals, then by mutual agreement the Parties can modify them through an amendment, according to Paragraph 13.6.

Time is Money Join Law Insider Premium to draft better contracts faster.